Array 5

Multiple Autoimmune Reactivity Screen™

Clinical Use

Measure Predictive Antibodies, some of which can appear up to ten years before the clinical onset of disease

Economically and efficiently assess possible tissue damage to multiple organs of the body

Recommended for Patients Who

A diagnosed autoimmune disorder, as they commonly develop additional autoimmune conditions

Chronic increased intestinal permeability, which is the gateway for environmentally-induced autoimmune disorders

Antigens Tested

Parietal Cell + ATPase IgG + IgA Combined
Intrinsic Factor IgG + IgA Combined
ASCA + ANCA IgG + IgA Combined
Tropomyosin IgG + IgA Combined
Thyroglobulin IgG + IgA Combined
Thyroid Peroxidase (TPO) IgG + IgA Combined
21 Hydroxylase (Adrenal Cortex) IgG + IgA Combined
Myocardial Peptide IgG + IgA Combined
Alpha-Myosin IgG + IgA Combined
Phospholipid IgG + IgA Combined
Platelet Glycoprotein IgG + IgA Combined
Ovary/Testis* IgG + IgA Combined
Fibulin IgG + IgA Combined
Collagen Complex IgG + IgA Combined
Arthritic Peptide IgG + IgA Combined
Osteocyte IgG + IgA Combined
Cytochrome P450 (Hepatocyte) IgG + IgA Combined
Insulin + Islet Cell Antigen IgG + IgA Combined
Glutamic Acid Decarboxylase 65 (GAD 65) IgG + IgA Combined
Myelin Basic Protein IgG + IgA Combined
Asialoganglioside IgG + IgA Combined
Alpha + Beta Tubulin IgG + IgA Combined
Cerebellar IgG + IgA Combined
Synapsin IgG + IgA Combined

CPT® Codes

CPT® CODE : 83516 (x24)

Potential Molecular Mechanisms Where Loss of Tolerance Exists

Illustration dramatized for visual purposes. © Cyrex Laboratories, LLC. All rights reserved.